CybeRelease: (OTC: VMCS) Targets 5% of the Oncology EMR Market
(CybeRelease, August 17, 2007) - Lake Harmony, Pa. - VisualMED Clinical Solutions Corp. (The “Company”) (OTC BB: VMCS) (Frankfurt: VA6.F) announces that it has begun a comprehensive sales effort, targeting some of the United States’ major cancer centers, with its flagship oncology module currently being implemented in Montreal, as recently reported.
Although it is not clear how many institutions or clinics handle cancer patients in the US, data show that there may be as many as 2000 such locations. It is estimated that about 20% of America’s 5000 hospitals support an oncology practice, and another 500 private clinics have a day center for treating cancer patients. The Company estimates that about 800 sites represent potential client installations in the intermediate term and believes it can win a 5% market share over the next 30 months in this niche.
Larger implementations within the Oncology departments of major healthcare institutions could be expected to follow with slightly longer implementation timeframes, but with much larger revenue generation over the long-term. In fact, in the few weeks following the start of its flagship oncology implementation, VisualMED has entered into preliminary discussions with 2 additional oncology day hospitals and 1 oncology clinic.
“Now that we have a world-class reference site we plan on investing the time and resources in pursuing deals in this key market as part of our diversification strategy. This is a focused sales effort on one departmental chief, one specialty, and a single medico-surgical domain which translates into a significantly shorter sales cycle than for our enterprise-wide system,” concludes Mr. Dab.
The demographic shift to an older population plus the availability of more effective therapy explains why oncology is one of the fastest growing medico-surgical specialties. As oncology practice becomes more complex, the perceived -- as well as real -- need for systems like VisualMED will become part of the public’s expectations for evidence-based safe practice.
VisualMED Clinical Solutions Corp. markets and distributes clinical management solutions that help hospitals and healthcare authorities reduce medication errors, increase personnel efficiency and bring down operating costs. One of its key decision support components is a core solution in the new agenda to promote greater patient safety and reduce risks due to medication errors.
Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com.
To read the complete release, go to http://biz.yahoo.com/iw/070816/0291929.html
CybeRelease Gainers are First Charter Corporation (Nasdaq: FCTR), Spartan Motors, Inc. (Nasdaq: SPAR), Citizens Republic Bancorp, Inc. (Nasdaq: CRBC), Sterling Bancshares, Inc. (Nasdaq: SBIB), Susquehanna Bancshares, Inc. (Nasdaq: SUSQ), Santarus, Inc. (Nasdaq: SNTS) and ICO Global Communications Holdings Limited DE (Nasdaq: ICOG).
CybeRelease Decliners are Akamai Technologies, Inc. (Nasdaq: AKAM), Pan American Silver Corp. (Nasdaq: PAAS), Melco PBL Entertainment (Macau) Limited (Nasdaq: MPEL), Home Solutions of America, Inc. (Nasdaq: HSOA), Xinhua Finance Media Limited (Nasdaq: XFML), Clean Energy Fuels Corp. (Nasdaq: CLNE) and TBS International Limited (Nasdaq: TBSI).
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
- Contact Information
- C. P. Barry
- Media Contact
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.